Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Epileptic Patients
NCT05722951Phase 3Completed
- Sponsor
- Tanta University
- Start
- Oct 2022
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in epilepsy, sponsored by Tanta University. Started Oct 2022; status: completed.
02
Drugs
metformin
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05722951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05722951.